Search Result "F317L."
Mutation Analysis of ABL1 Gene and its Relation to the Achievement of Major Molecular Response in Indonesian Chronic Myeloid Leukemia Patients
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 17 Issue: 1 Year: 2020 Page: 48-54
Author(s): Reni Widyastuti,Melva Louisa,Ikhwan Rinaldi,Riki Nova,Instiaty Instiaty,Rizky Priambodo
In Silico Identification and Analysis of Drug Resistant Mutants of ABL Tyrosine Kinase Based on Detrimental Missense Mutations
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 3 Year: 2011 Page: 396-404
Author(s): R. Rajasekaran, C. George Priya Doss, G. Arun Prasad, Rao Sethumadhavan
Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy
Journal: Current Drug Metabolism
Volume: 18 Issue: 3 Year: 2017 Page: 199-206
Author(s): Ruiqing Wang,Chaoqin Zhong,Chen Zhang,Mingqiang Hua,Daoxin Ma
Chronic Myeloid Leukemia: Existing Therapeutic Options and Strategies to Overcome Drug Resistance
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 4 Year: 2019 Page: 333-345
Author(s): Vivek Kumar Singh,Mohane Selvaraj Coumar
Dasatinib in the Treatment of Chronic Myeloid Leukemia
Journal: Current Signal Transduction Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 99-105
Author(s): Joanna Gora-Tybor, Tadeusz Robak
Second Generation Abl Tyrosine Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone (Second Edition)
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Shinya Kimura
Doi: 10.2174/978160805161811001010116
Allosteric Inhibitors of Bcr-Abl: Towards Novel Myristate-Pocket Binders
Journal: Current Pharmaceutical Biotechnology
Volume: 14 Issue: 5 Year: 2013 Page: 477-487
Author(s): Marco Radi,Silvia Schenone,Maurizio Botta
Design Strategies, Structures and Molecular Interactions of Small Molecule Src Inhibitors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 16 Issue: 8 Year: 2016 Page: 992-1002
Author(s): Sureyya Olgen
BCR-ABL Inhibitors in Chronic Myeloid Leukemia: Process Chemistry and Biochemical Profile
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2943-2959
Author(s): F. Leonetti, A. Stefanachi, O. Nicolotti, M. Catto, L. Pisani, S. Cellamare, A. Carotti
Second-Generation Tyrosine Kinase Inhibitors as First-Line Treatment Strategy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 4 Year: 2012 Page: 391-401
Author(s): M. Breccia,G. Alimena